Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Original Article from The New England Journal of Medicine — Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

  • Interesting agent with both SGLT2 and SGLT1 inhibition. too bad it was stopped early, but a stunning result none the less.